Lymphocytes in atherosclerosis.

Immune function in Amazonian horticulturalists. Ann Hum Biol (2016) 0.86

A change in inflammatory footprint precedes plaque instability: a systematic evaluation of cellular aspects of the adaptive immune response in human atherosclerosis. J Am Heart Assoc (2015) 0.86

Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritis. Clin Transl Immunology (2016) 0.84

Atherosclerosis and the role of immune cells. World J Clin Cases (2015) 0.83

Th17 cells and IL-17 are involved in the disruption of vulnerable plaques triggered by short-term combination stimulation in apolipoprotein E-knockout mice. Cell Mol Immunol (2013) 0.82

Plasma IL-5 concentration and subclinical carotid atherosclerosis. Atherosclerosis (2014) 0.79

B Cells and Atherosclerosis. Am J Physiol Heart Circ Physiol (2017) 0.77

Cardiovascular disease and type 2 diabetes in evolutionary perspective: a critical role for helminths? Evol Med Public Health (2016) 0.76

Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis. Am J Transl Res (2016) 0.75

Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE(-/-) mice. Sci Rep (2016) 0.75

T-Cells Specific for a Self-Peptide of ApoB-100 Exacerbate Aortic Atheroma in Murine Atherosclerosis. Front Immunol (2017) 0.75

Perivascular Adipose Tissue Harbors Atheroprotective IgM-Producing B Cells. Front Physiol (2017) 0.75

The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy. Oncotarget (2017) 0.75

Assessment of gold nanoparticles on human peripheral blood cells by metabolic profiling with 1H-NMR spectroscopy, a novel translational approach on a patient-specific basis. PLoS One (2017) 0.75

Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol (2004) 2.41

Expressed sequence tag-linked microsatellites as a source of gene-associated polymorphisms for detecting signatures of divergent selection in atlantic salmon (Salmo salar L.). Mol Biol Evol (2005) 1.77

Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice. J Am Coll Cardiol (2007) 1.77

Inhibitory effect on arterial injury-induced neointimal formation by adoptive B-cell transfer in Rag-1 knockout mice. Arterioscler Thromb Vasc Biol (2002) 1.59

Short communication: Dating components of human atherosclerotic plaques. Circ Res (2010) 1.54

HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2003) 1.48

Elevated CD14++CD16- monocytes predict cardiovascular events. Circ Cardiovasc Genet (2012) 1.40

Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arterioscler Thromb Vasc Biol (2010) 1.31

Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism (2004) 1.26

Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. Circulation (2004) 1.19

Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler Thromb Vasc Biol (2003) 1.19

Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation. Arterioscler Thromb Vasc Biol (2012) 1.17

Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation. EMBO Mol Med (2012) 1.16

Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia. PLoS One (2010) 1.13

Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia. Arterioscler Thromb Vasc Biol (2009) 1.08

Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease. Arterioscler Thromb Vasc Biol (2003) 1.08

Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke. Arterioscler Thromb Vasc Biol (2012) 1.07

Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice. Arterioscler Thromb Vasc Biol (2012) 1.06

Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence. Atherosclerosis (2012) 1.03

CRP--marker or maker of cardiovascular disease? Arterioscler Thromb Vasc Biol (2005) 1.02

Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2005) 1.02

T cell modulation of intimal thickening after vascular injury: the bimodal role of IFN-gamma in immune deficiency. Arterioscler Thromb Vasc Biol (2005) 1.00

FcgammaRIIB inhibits the development of atherosclerosis in low-density lipoprotein receptor-deficient mice. J Immunol (2010) 1.00

CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ mice. BMC Immunol (2010) 1.00

T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke. Arterioscler Thromb Vasc Biol (2013) 0.98

High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction. Eur Heart J (2008) 0.98

Vaccination against atherosclerosis? Induction of atheroprotective immunity. Semin Immunopathol (2009) 0.97

Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression. Autoimmunity (2005) 0.97

Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages. Biochem Biophys Res Commun (2008) 0.96

Perilipin and adipophilin expression in lipid loaded macrophages. Biochem Biophys Res Commun (2007) 0.94

Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events. Atherosclerosis (2007) 0.94

Interleukin-1beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells. BMC Immunol (2008) 0.94

Changes related to age and cerebrovascular symptoms in the extracellular matrix of human carotid plaques. Stroke (2003) 0.93

Development of a diet quality index assessing adherence to the Swedish nutrition recommendations and dietary guidelines in the Malmö Diet and Cancer cohort. Public Health Nutr (2011) 0.93

The vascular repair process after injury of the carotid artery is regulated by IL-1RI and MyD88 signalling. Cardiovasc Res (2011) 0.92

Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model. J Biol Chem (2001) 0.91

Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease. Stroke (2007) 0.91

Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages. Lipids Health Dis (2006) 0.91

Plasma S100A8/A9 correlates with blood neutrophil counts, traditional risk factors, and cardiovascular disease in middle-aged healthy individuals. Arterioscler Thromb Vasc Biol (2013) 0.89

High disaccharide intake associates with atherogenic lipoprotein profile. Br J Nutr (2011) 0.89

A high diet quality is associated with lower incidence of cardiovascular events in the Malmö diet and cancer cohort. PLoS One (2013) 0.89

B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10. Thromb Haemost (2015) 0.89

Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses. Circulation (2011) 0.88

Alternate trains of postural muscle vibration promote cyclic body displacement in standing parkinsonian patients. Mov Disord (2008) 0.87

Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100. Atherosclerosis (2006) 0.87

Shortened life span, bradycardia, and hypotension in mice with targeted expression of an Igf2 transgene in smooth muscle cells. Endocrinology (2003) 0.87

Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells. Circ Res (2009) 0.87

Treatment with beta-blockers is associated with lower levels of Lp-PLA2 and suPAR in carotid plaques. Cardiovasc Pathol (2013) 0.86

Very low-density lipoprotein induces interleukin-1beta expression in macrophages. Biochem Biophys Res Commun (2005) 0.86

Cystatin C and cathepsins in cardiovascular disease. Front Biosci (2008) 0.86

TAP1-deficiency does not alter atherosclerosis development in Apoe-/- mice. PLoS One (2012) 0.85

Will autoantibodies help to determine severity and progression of atherosclerosis? Curr Opin Lipidol (2004) 0.85

Autoantibodies against modified low-density lipoproteins in coronary artery disease. Atherosclerosis (2003) 0.85

Simvastatin stimulates macrophage interleukin-1beta secretion through an isoprenylation-dependent mechanism. Vascul Pharmacol (2006) 0.85

Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice. PLoS One (2013) 0.84

Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis. Cardiovasc Res (2011) 0.84

Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice. Atherosclerosis (2005) 0.84

Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury. Circ Res (2007) 0.84

Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice. Biochem Biophys Res Commun (2005) 0.83

Linoleic acid-stimulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-kappaB activation. Metabolism (2002) 0.83

Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol (2012) 0.83

Screen for Footprints of Selection during Domestication/Captive Breeding of Atlantic Salmon. Comp Funct Genomics (2012) 0.83

Elastin and calcium rather than collagen or lipid content are associated with echogenicity of human carotid plaques. Stroke (2004) 0.83

Timing affects the efficacy of LDL immunization on atherosclerotic lesions in apo E (-/-) mice. Atherosclerosis (2004) 0.82

Sex chromosome polymorphisms in Arctic charr and their evolutionary origins. Genome (2011) 0.82

Arm weight support training improves functional motor outcome and movement smoothness after stroke. Funct Neurol (2014) 0.82

Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice. Arterioscler Thromb Vasc Biol (2009) 0.81

Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment. J Am Coll Cardiol (2010) 0.81

Insulin-like growth factor II and its receptors in atherosclerosis and in conditions predisposing to atherosclerosis. Curr Opin Lipidol (2003) 0.81

Altered AP-1/Ref-1 redox pathway and reduced proliferative response in iNOS-deficient vascular smooth muscle cells. Vasc Med (2004) 0.81

Elastin- and collagen-rich human carotid plaques have increased levels of the cysteine protease inhibitor cystatin C. J Vasc Res (2008) 0.81

Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques. Arterioscler Thromb Vasc Biol (2005) 0.81

Ceylon cinnamon does not affect postprandial plasma glucose or insulin in subjects with impaired glucose tolerance. Br J Nutr (2011) 0.80

Limiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastases. HPB (Oxford) (2013) 0.80

Immune responses elicited by apoB-100-derived peptides in mice. Immunol Res (2013) 0.80

Scoring models of a diet quality index and the predictive capability of mortality in a population-based cohort of Swedish men and women. Public Health Nutr (2012) 0.80

Immunomodulation of atherosclerosis with a vaccine. Nat Clin Pract Cardiovasc Med (2005) 0.80

Very low density lipoprotein potentiates tumor necrosis factor-alpha expression in macrophages. Atherosclerosis (2005) 0.79

High Plasma Levels of Galectin-3 Are Associated with Increased Risk for Stroke after Carotid Endarterectomy. Cerebrovasc Dis (2016) 0.79

Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice. Autoimmunity (2007) 0.79

Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide. J Lipid Res (2006) 0.79

Decreased inducibility of TNF expression in lipid-loaded macrophages. BMC Immunol (2002) 0.79

Regulating protective immunity in atherosclerosis. Circ Res (2005) 0.79

Long-term treatment with low-dose metoprolol CR/XL is associated with increased plaque echogenicity: the Beta-blocker Cholesterol-lowering Asymptomatic Plaque Study (BCAPS). Atherosclerosis (2011) 0.78

The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- mice. Nephrol Dial Transplant (2010) 0.78

Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions. Atherosclerosis (2008) 0.78

Circulating CD40+ and CD86+ B cell subsets demonstrate opposing associations with risk of stroke. Arterioscler Thromb Vasc Biol (2013) 0.78

Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus. Clin Exp Immunol (2015) 0.78

Increased inflammation in atherosclerotic lesions of diabetic Akita-LDLr⁻/⁻ mice compared to nondiabetic LDLr⁻/⁻ mice. Exp Diabetes Res (2012) 0.78

Mobilization of regulatory T cells in response to carotid injury does not influence subsequent neointima formation. PLoS One (2012) 0.78

Immunization for atherosclerosis. Curr Atheroscler Rep (2007) 0.77

Immune mechanisms in atherosclerosis and potential for an atherosclerosis vaccine. Discov Med (2011) 0.77

Vaccination for atherosclerosis: a novel therapeutic paradigm. Expert Rev Vaccines (2004) 0.77

Can continuous physical training counteract aging effect on myoelectric fatigue? A surface electromyography study application. Arch Phys Med Rehabil (2003) 0.77

Low density lipoprotein stimulation of human macrophage proteoglycan secretion. Biochem Biophys Res Commun (2005) 0.77

Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men. Metabolism (2008) 0.77

Active and passive immunization for atherosclerosis. Curr Opin Mol Ther (2007) 0.77

Cassia cinnamon does not change the insulin sensitivity or the liver enzymes in subjects with impaired glucose tolerance. Nutr J (2014) 0.76

Immunization with cationized BSA inhibits progression of disease in ApoBec-1/LDL receptor deficient mice with manifest atherosclerosis. Immunobiology (2010) 0.76